zileuton has been researched along with pterostilbene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balamurali, MM; Basu, B; Doble, M; Munussami, P; Muthuraman, S; Saravana Kumar, R; Sinha, S; Vasavi, CS; Waidha, KM | 1 |
| Alessio, N; Ambruosi, M; Banoglu, E; Boccellino, M; Bruno, F; De Rosa, M; Donniacuo, M; Filosa, R; Fiorentino, A; Kahn, H; Massa, A; Olgaç, A; Pace, S; Quagliuolo, L; Rinaldi, B; Werz, O | 1 |
2 other study(ies) available for zileuton and pterostilbene
| Article | Year |
|---|---|
Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies.
Topics: Antioxidants; Arachidonate 5-Lipoxygenase; Catalytic Domain; Drug Design; Enzyme Assays; Humans; Hydroxyurea; Lipoxygenase Inhibitors; Molecular Docking Simulation; Molecular Structure; Peroxidases; Piperidines; Structure-Activity Relationship | 2019 |
Protective effect of piceatannol and bioactive stilbene derivatives against hypoxia-induced toxicity in H9c2 cardiomyocytes and structural elucidation as 5-LOX inhibitors.
Topics: Animals; Arachidonate 5-Lipoxygenase; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Hypoxia; Lipoxygenase Inhibitors; Molecular Structure; Myocytes, Cardiac; Protective Agents; Rats; Stilbenes; Structure-Activity Relationship | 2019 |